Shandong Lukang Pharmaceutical Co Ltd (600789) — Cash Flow-to-Debt Ratio
Shandong Lukang Pharmaceutical Co Ltd (600789) has a Cash Flow-to-Debt Ratio of 0.00x as of September 2025, meaning its operating cash flow of CN¥-6.39 Million could theoretically repay 0% of its total liabilities (CN¥4.71 Billion) in one year. See 600789 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shandong Lukang Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for Shandong Lukang Pharmaceutical Co Ltd across 28 annual periods. For the full cash flow conversion analysis, see 600789 cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Shandong Lukang Pharmaceutical Co Ltd (1998–2025)
Year-by-year debt coverage analysis for Shandong Lukang Pharmaceutical Co Ltd. Check Shandong Lukang Pharmaceutical Co Ltd (600789) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.15x | CN¥698.17 Million | CN¥4.78 Billion | ▲ +82.7% |
| 2024 | 0.08x | CN¥402.82 Million | CN¥5.04 Billion | ▼ -33.0% |
| 2023 | 0.12x | CN¥604.01 Million | CN¥5.06 Billion | ▲ +40.2% |
| 2022 | 0.09x | CN¥444.38 Million | CN¥5.22 Billion | ▲ +150.3% |
| 2021 | 0.03x | CN¥149.33 Million | CN¥4.39 Billion | ▼ -43.2% |
| 2020 | 0.06x | CN¥234.55 Million | CN¥3.91 Billion | ▼ -35.1% |
| 2019 | 0.09x | CN¥361.87 Million | CN¥3.92 Billion | ▼ -8.0% |
| 2018 | 0.10x | CN¥351.09 Million | CN¥3.50 Billion | ▲ +13.1% |
| 2017 | 0.09x | CN¥275.51 Million | CN¥3.10 Billion | ▼ -34.2% |
| 2016 | 0.13x | CN¥296.23 Million | CN¥2.20 Billion | ▲ +263.6% |
| 2015 | 0.04x | CN¥78.39 Million | CN¥2.11 Billion | ▼ -11.8% |
| 2014 | 0.04x | CN¥108.56 Million | CN¥2.58 Billion | ▼ -60.0% |
| 2013 | 0.11x | CN¥256.50 Million | CN¥2.44 Billion | ▲ +117.0% |
| 2012 | 0.05x | CN¥115.20 Million | CN¥2.38 Billion | ▼ -29.8% |
| 2011 | 0.07x | CN¥123.28 Million | CN¥1.79 Billion | ▼ -69.9% |
| 2010 | 0.23x | CN¥308.88 Million | CN¥1.35 Billion | ▲ +6.8% |
| 2009 | 0.21x | CN¥199.49 Million | CN¥930.38 Million | ▲ +2.5% |
| 2008 | 0.21x | CN¥209.39 Million | CN¥1.00 Billion | ▲ +59.8% |
| 2007 | 0.13x | CN¥137.30 Million | CN¥1.05 Billion | ▲ +134.3% |
| 2006 | 0.06x | CN¥56.24 Million | CN¥1.01 Billion | ▼ -62.4% |
| 2005 | 0.15x | CN¥161.64 Million | CN¥1.09 Billion | ▲ +182.8% |
| 2004 | 0.05x | CN¥63.24 Million | CN¥1.20 Billion | ▼ -66.0% |
| 2003 | 0.15x | CN¥167.42 Million | CN¥1.08 Billion | ▼ -46.0% |
| 2002 | 0.29x | CN¥315.59 Million | CN¥1.10 Billion | ▲ +29.1% |
| 2001 | 0.22x | CN¥270.43 Million | CN¥1.22 Billion | ▲ +1031.5% |
| 2000 | 0.02x | CN¥22.36 Million | CN¥1.14 Billion | ▼ -61.3% |
| 1999 | 0.05x | CN¥35.12 Million | CN¥691.92 Million | ▼ -52.1% |
| 1998 | 0.11x | CN¥46.18 Million | CN¥435.91 Million | — |